Björn Nashan - Concepedia

Author

Björn Nashan

Also Known As

B NASHAN, B Nashan, B. NASHAN, B. Nashan, B. Nashan, BJÖRN NASHAN, Björn Nashan, Bj?? Nashan, Bj??rn Nashan, Bjoern Nashan

561

Publications

17.8K

Citations

H-Index

195

Concepts

All Affiliations

Medizinische Hochschule Hannover University Medical Center Hamburg-Eppendorf Universität Hamburg University of Science and Technology of China Charité - Universitätsmedizin Berlin

About

Björn Nashan is an author at Medizinische Hochschule Hannover specializing in medicine, immunology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	93	5K
2	Health Sciences	12	13	441
3	Engineering	3	3	221
4	Arts	1	1	44
5	Education	1	1	14

Björn Nashan

213

Publications

15K

Citations

H-Index

Page 1

	Year	Citations
Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation Henrik Ekberg, Hélio Tedesco‐Silva, A. Demirbaş, New England Journal of Medicine	2007	1.8K
Costimulation Blockade with Belatacept in Renal Transplantation Flavio Vincenti, Christian P. Larsen, Antoine Dürrbach, New England Journal of Medicine	2005	851
Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients Björn Nashan, Richard H. Moore, P L Amlot, The Lancet Transplant RejectionUrologyTransplantationAcute Cellular RejectionKidney Transplant	1997	761
Metabolic syndrome in liver transplant recipients: Prevalence and association with major vascular events Marie Laryea, Kymberly D. Watt, Michele Molinari, Liver Transplantation Liver Transplant RecipientsMetabolic DisorderSolid Organ TransplantationTransplantation MedicinePosttransplantation Metabolic Syndrome	2007	312
REDUCTION OF ACUTE RENAL ALLOGRAFT REJECTION BY DACLIZUMAB1 Björn Nashan, Susan Light, Ian R. Hardie, Transplantation	1999	308
Cyclosporine Sparing with Mycophenolate Mofetil, Daclizumab and Corticosteroids in Renal Allograft Recipients: The CAESAR Study Henrik Ekberg, Josep M. Grinyó, Björn Nashan, American Journal of Transplantation GlomerulonephritisUrologyTransplantationMycophenolate MofetilKidney Transplant	2007	290
First Human Trial of FTY720, a Novel Immunomodulator, in Stable Renal Transplant Patients Klemens Budde, Robert Schmouder, R. Brunkhorst, Journal of the American Society of Nephrology	2002	273
MULTICENTER TRIAL EXPLORING CALCINEURIN INHIBITORS AVOIDANCE IN RENAL TRANSPLANTATION Flavio Vincenti, Eleanor L. Ramos, C Brattström, Transplantation	2001	264
Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study Hans J. Schlitt, Annette Barkmann, Klaus H.W. Böker, The Lancet UrologyMycophenolate MofetilKidney TransplantMedicineKidney Transplantation	2001	254
Presence of EpCAM‐positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma Kornelius Schulze, Christin Gasch, Katharina Staufer, International Journal of Cancer	2013	245

Page 1